Home
Conditions
Leukemia, Lymphoid

Clinical trial condition

Leukemia, Lymphoid

Explore clinical trials studying Leukemia, Lymphoid. Study availability and eligibility vary by location and protocol.

3,018 public trials 549 recruiting studies

Refine in advanced search Browse all conditions

Leukemia, Lymphoid trial results

Completed

TC-110 T Cells in Adults With Relapsed or Refractory Non-Hodgkin Lymphoma or Acute Lymphoblastic Leukemia

NCT04323657

Conditions: Acute Lymphoblastic Leukemia, Diffuse Large B Cell Lymphoma, Follicular Lymphoma, +20 more
Locations: Colorado Blood Cancer Institute Denver, Colorado, United States

Sarah Cannon Research Institute Nashville, Tennessee, United States

University of Texas MD Anderson Cancer Center Houston, Texas, United States

View Trial Details

Completed

Oral Clofarabine for Relapsed/Refractory Non-Hodgkin Lymphoma

NCT00644189

Conditions: Anaplastic Large-Cell Lymphoma, Angioimmunoblastic T-cell Lymphoma, Chronic Disease, +35 more
Locations: Massachusetts General Hospital Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Study of the Prognostic Role of Gene Polymorphism in the Development of B-cell Leukemias and Lymphomas in Children of Kazakh Nationality

NCT05095155

Conditions: B Cell Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +10 more
Locations: Scientific Center of Pediatrics and Pediatric Surgery Almaty, Kazakhstan

View Trial Details

Completed

A Phase II Study on Allogeneic Stem Cell Transplantation in Patients With Active Acute Leukemia

NCT01814488

Conditions: Acute Leukemia, Hematologic Diseases, Hemic and Lymphatic Diseases, +11 more
Locations: Azienda Ospedaliera SS Antonio e Biagio Alessandria, Italy

Policlinico Bari, Italy

Divisione di Ematologia - Ospedali Papa Giovanni XXIII Bergamo, Italy

Ospedale San Orsola Bologna, Italy

View all 30 locations

View Trial Details

Completed

Thymoglobuline Versus Alemtuzumab in Patients Undergoing Allogeneic Transplant

NCT00354120

Conditions: Acute Myeloblastic Leukemia, Anemia, Anemia, Refractory, +28 more
Locations: Ematologia e Centro Trapianti Midollo Osseo - Ospedale IRCCS Casa Sollievo della Sofferenza San Giovanni Rotondo, Foggia, Italy

Divisione Ematologia - Ospedale "SS. Antonio, Biagio e Cesare Arrigo" Alessandria, Italy

Clinica di Ematologia - Ospedali Riuniti di Ancona Ancona, Italy

Divisione di Ematologia - Ospedali Riuniti Bergamo Bergamo, Italy

View all 22 locations

View Trial Details

Completed

Comparing Body Composition Assessment Methods

NCT04610918

Conditions: Body Composition, Gastrointestinal Failure, Hematologic Diseases, +11 more
Locations: Hospital for Sick Children Toronto, Ontario, Canada

View Trial Details

Completed

Pediatric Pain Management - an Intervention Study

NCT03385681

Conditions: Agnosia, Hematologic Diseases, Hemic and Lymphatic Diseases, +21 more
Locations: Haukeland University Hospital Bergen, Norway

Akershus University hospital Lillestrøm, Norway

Oslo University Hospital Oslo, Norway

Stavanger University Hospital Stavanger, Norway

View Trial Details

Completed

A Study Evaluating the Impact of Venetoclax on the Quality of Life for Subjects With Relapsed (Your Cancer Has Come Back) or Refractory (no Response to Previous Cancer Treatments) Chronic Lymphocytic Leukemia (CLL) While Receiving Venetoclax Monotherapy (a Single Agent).

NCT02980731

Conditions: Chromosome 17 deletion, Chronic Disease, Chronic Lymphocytic Leukemia (CLL), +15 more
Locations: Hospital Italiano La Plata /ID# 150812 La Plata, Buenos Aires, Argentina

Fundaleu /Id# 150811 Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina

Cemic /Id# 150810 Ciudad Autonoma de Buenos Aire, Ciuadad Autonoma de Buenos Aires, Argentina

Sanatorio Allende /ID# 150813 Córdoba, Argentina

View all 33 locations

View Trial Details

Completed

Pyrimethamine for the Treatment of Relapsed Chronic Lymphocytic Leukemia/Small Lymphocytic Lymphoma

NCT01066663

Conditions: Chronic Disease, Chronic Lymphocytic Leukemia, Disease Attributes, +16 more
Locations: Beth Israel Deaconess Medical Center Boston, Massachusetts, United States

Dana-Farber Cancer Institute Boston, Massachusetts, United States

View Trial Details

Completed

Phase I Trial of Universal Donor NK Cell Therapy in Combination With ALT803

NCT02890758

Conditions: Acute Lymphoblastic Leukemia, Acute Myeloid Leukemia, Adenocarcinoma of Rectum, +65 more
Locations: University Hospitals Cleveland Medical Center, Case Comprehensive Cancer Center Cleveland, Ohio, United States

View Trial Details

Leukemia, Lymphoid

Leukemia, Lymphoid trial results

Related conditions